Unicycive Therapeutics' UNI-494 Granted Orphan Drug Designation by FDA: A Leap Forward for Kidney Transplant Patients.
Orphan Drug Designation Granted By FDA For Major Medical Company
Orphan Drug Designation Granted By FDA For…
Orphan Drug Designation Granted By FDA For Major Medical Company
Unicycive Therapeutics' UNI-494 Granted Orphan Drug Designation by FDA: A Leap Forward for Kidney Transplant Patients.